Manfred Reiter

1.1k total citations
38 papers, 757 citations indexed

About

Manfred Reiter is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Manfred Reiter has authored 38 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Epidemiology. Recurrent topics in Manfred Reiter's work include Viral Infectious Diseases and Gene Expression in Insects (17 papers), Virus-based gene therapy research (7 papers) and Influenza Virus Research Studies (7 papers). Manfred Reiter is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (17 papers), Virus-based gene therapy research (7 papers) and Influenza Virus Research Studies (7 papers). Manfred Reiter collaborates with scholars based in Austria, Germany and Portugal. Manfred Reiter's co-authors include Leopold Grillberger, Wolfgang Mundt, Thomas R. Kreil, Otfried Kistner, Christa Tauer, Perry Barrett, Helga Savidis-Dacho, Friedrich Dorner, Brian A. Crowe and P Brühl and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Manfred Reiter

34 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Reiter Austria 17 311 213 204 146 114 38 757
H. Baumgarten Germany 9 284 0.9× 144 0.7× 636 3.1× 202 1.4× 24 0.2× 12 944
Leopold Grillberger Austria 9 115 0.4× 165 0.8× 161 0.8× 179 1.2× 80 0.7× 12 474
Marcella Sarzotti‐Kelsoe United States 14 217 0.7× 349 1.6× 185 0.9× 389 2.7× 61 0.5× 27 929
Christa Tauer Austria 14 415 1.3× 384 1.8× 233 1.1× 451 3.1× 23 0.2× 19 1.2k
R. Nayak India 18 533 1.7× 256 1.2× 312 1.5× 241 1.7× 17 0.1× 58 1.0k
Mark Manak United States 16 158 0.5× 383 1.8× 252 1.2× 82 0.6× 19 0.2× 40 824
Elles Simonetti Netherlands 14 191 0.6× 170 0.8× 251 1.2× 306 2.1× 80 0.7× 35 832
Linus Backert Germany 13 652 2.1× 299 1.4× 80 0.4× 457 3.1× 42 0.4× 18 1.0k
Stefanie A. Krumm United States 19 414 1.3× 314 1.5× 421 2.1× 170 1.2× 14 0.1× 26 1.0k
Irina Ionescu‐Matiu United States 12 287 0.9× 84 0.4× 287 1.4× 255 1.7× 19 0.2× 13 670

Countries citing papers authored by Manfred Reiter

Since Specialization
Citations

This map shows the geographic impact of Manfred Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Reiter more than expected).

Fields of papers citing papers by Manfred Reiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Reiter. The network helps show where Manfred Reiter may publish in the future.

Co-authorship network of co-authors of Manfred Reiter

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Reiter. A scholar is included among the top collaborators of Manfred Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Reiter. Manfred Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reiter, Manfred, et al.. (2024). Streamlining the purification of a clinical-grade oncolytic virus for therapeutic applications. Separation and Purification Technology. 354. 128769–128769. 3 indexed citations
2.
Reiter, Manfred, et al.. (2023). Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus. Biotechnology and Bioengineering. 120(11). 3335–3346. 8 indexed citations
3.
Dockal, Michael, Michael Graninger, Meinhard Hasslacher, et al.. (2011). Expression of recombinant human coagulation factors VII (rFVII) and IX (rFIX) in various cell types, glycosylation analysis, and pharmacokinetic comparison. BMC Proceedings. 5(S8). P23–P23. 4 indexed citations
4.
Wressnigg, Nina, Daniel Voß, Thorsten Wolff, et al.. (2009). Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate. Vaccine. 27(21). 2851–2857. 29 indexed citations
5.
Grillberger, Leopold, et al.. (2009). Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnology Journal. 4(2). 186–201. 95 indexed citations
6.
Kistner, Otfried, M. Keith Howard, Martin Spruth, et al.. (2007). Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine. 25(32). 6028–6036. 87 indexed citations
7.
Kistner, Otfried, N Barrett, Manfred Reiter, et al.. (2007). The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans. Vaccine. 25(25). 4845–4852. 25 indexed citations
8.
Hogenboom, D. L., et al.. (1997). Volume Changes Attending Hydration of Quenched Magnesium Sulfate Brine: The Tectonics of Ganymede's Sulci. LPI. 579. 4 indexed citations
9.
Fischer, B., Uwe Schlokat, Manfred Reiter, Wolfgang Mundt, & Friedrich Dorner. (1997). Biochemical and functional characterization of recombinant von Willebrand factor produced on a large scale. Cellular and Molecular Life Sciences. 53(11-12). 943–950. 17 indexed citations
11.
Fischer, Bernhard, Artur Mitterer, Manfred Reiter, et al.. (1996). EFFECT OF MULTIMERIZATION OF HUMAN AND RECOMBINANT VON WILLEBRAND FACTOR ON PLATELET AGGREGATION, BINDING TO COLLAGEN AND BINDING OF COAGULATION FACTOR VIII. Thrombosis Research. 84(1). 55–66. 55 indexed citations
12.
Fischer, Bernhard, Uwe Schlokat, Artur Mitterer, et al.. (1996). Rational Design, Recombinant Preparation, and in Vitro and in Vivo Characterization of Human Prothrombin-derived Hirudin Antagonists. Journal of Biological Chemistry. 271(39). 23737–23742. 2 indexed citations
13.
Fischer, Bernhard, Uwe Schlokat, Artur Mitterer, et al.. (1995). Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co‐expressing recombinant furin. FEBS Letters. 375(3). 259–262. 22 indexed citations
14.
Wimmer, Katharina, et al.. (1994). Two-dimensional gel electrophoresis for controlling and comparing culture supernatants of mammalian cell culture productions systems. Cytotechnology. 16(3). 137–146. 3 indexed citations
15.
Harant, Hanna, Katharina Wimmer, Elisabeth Wenisch, et al.. (1992). Two-dimensional electrophoresis as a tool for control of quality and consistency in production systems using animal cells. Cytotechnology. 8(2). 119–127. 5 indexed citations
17.
Borth, Nicole, et al.. (1992). Determination of division rates of rCHO cells in high density and immobilized fermentation systems by flow cytometry. Cytotechnology. 8(3). 207–214. 1 indexed citations
18.
Reiter, Manfred, et al.. (1991). Modular Integrated Fluidized Bed Bioreactor Technology. Bio/Technology. 9(11). 1100–1102. 23 indexed citations
19.
Reiter, Manfred, et al.. (1990). High density microcarrier culture with a new device which allows oxygenation and perfusion of microcarrier cultures. Cytotechnology. 3(1). 39–42. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026